Raymond James Financial Services Advisors’s Minerva Neurosciences NERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,500
| Closed | -$16K | – | 3332 |
|
|
2021
Q4 | $16K | Buy |
2,500
+375
| +18% | +$2.4K | ﹤0.01% | 3216 |
|
|
2021
Q3 | $30K | Sell |
2,125
-2,500
| -54% | -$35.3K | ﹤0.01% | 3193 |
|
|
2021
Q2 | $86K | Buy |
4,625
+250
| +6% | +$4.65K | ﹤0.01% | 3145 |
|
|
2021
Q1 | $102K | Sell |
4,375
-22
| -0.5% | -$513 | ﹤0.01% | 3024 |
|
|
2020
Q4 | $82K | Buy |
4,397
+9
| +0.2% | +$168 | ﹤0.01% | 2862 |
|
|
2020
Q3 | $112K | Hold |
4,388
| – | – | ﹤0.01% | 2667 |
|
|
2020
Q2 | $127K | Buy |
4,388
+1,263
| +40% | +$36.6K | ﹤0.01% | 2584 |
|
|
2020
Q1 | $151K | Sell |
3,125
-625
| -17% | -$30.2K | ﹤0.01% | 2141 |
|
|
2019
Q4 | $213K | Buy |
3,750
+625
| +20% | +$35.5K | ﹤0.01% | 2534 |
|
|
2019
Q3 | $194K | Sell |
3,125
-625
| -17% | -$38.8K | ﹤0.01% | 2511 |
|
|
2019
Q2 | $169K | Buy |
3,750
+1,250
| +50% | +$56.3K | ﹤0.01% | 2574 |
|
|
2019
Q1 | $157K | Hold |
2,500
| – | – | ﹤0.01% | 2552 |
|
|
2018
Q4 | $135K | Buy |
2,500
+625
| +33% | +$33.8K | ﹤0.01% | 2350 |
|
|
2018
Q3 | $188K | Buy |
+1,875
| New | +$188K | ﹤0.01% | 2540 |
|
|
2018
Q2 | – | Sell |
-1,750
| Closed | -$88K | – | 2789 |
|
|
2018
Q1 | $88K | Buy |
+1,750
| New | +$88K | ﹤0.01% | 2386 |
|